FPGEE 2025 Practice Exam for NABP – The Complete All-in-One Guide to Exam Success!

The Prescription Marketing Act of 1987 plays a crucial role in regulating the pharmaceutical industry, particularly concerning the distribution of prescription drugs. One of its key provisions prohibits the re-importation of prescription drugs into the United States, allowing this activity solely for the original manufacturers. This is primarily aimed at ensuring the safety and integrity of pharmaceuticals that are distributed within the U.S. It seeks to combat potential issues such as counterfeit medications or those that may have been stored improperly during re-importation.

Re-importation could lead to numerous public health concerns, including variations in formulation, handling errors, and quality control challenges. By restricting this process, the act aims to maintain a consistent and safe supply of medications within the U.S. market.

In contrast, advertising for prescription drugs, direct-to-consumer sales, and online pharmacy sales are governed by other regulations and are not specifically prohibited by this act. Therefore, it’s this specific focus on re-importation that underscores the significance of the correct answer.